OTTAWA, Nov. 19 /PRNewswire/ - Vocantas Inc., developer of voice solutions for healthcare, has been selected by Boston's Brigham and Women's Hospital (BWH) to help researchers assess the impact of automated telephone follow-up systems on the management of patients on commonly prescribed medications. Using interactive voice response (IVR) and speech technology, the CallAssure system enables healthcare providers to evaluate real time patient data. Study researchers believe that this proactive outreach may facilitate communication between patients and their physicians between visits to address potentially serious issues.
Leading the project is researcher Jennifer Haas, MD, MSPH, at BWH's Division of General Medicine. Dr. Haas has made major contributions in areas focused on the use of technology to improve the quality and safety of patient care, as well as access to care, particularly among the poor and uninsured.
"After three weeks of pilot test calls, the system is functioning well," says Haas. "We are looking forward to implementing the technology in our trial to quickly and effectively reach participants and to manage the data efficiently."
Supporting HL7 standards, the CallAssure system automatically records any symptoms the patient is experiencing in a note which is then attached to the patient's electronic medical record.
Primary care patients at BWH who are prescribed any of 32 target medications for a range of chronic conditions, from allergies to high cholesterol, are enrolled in the study. Candidates receive a letter explaining how the study works, and may choose to opt out. More than 90% of patients have chosen to try the program at the time of this release.
Aarthi Iyer, MPH with the Division of General Medicine at BWH, explains that there are a number of potential problems that exist with identifying side effects from prescribed medications.
"Typically, medication follow-up is done during the n
Copyright©2008 PR Newswire.
All rights reserved